Your browser doesn't support javascript.
loading
Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment.
Noguchi, Masanori; Mine, Takashi; Yamada, Akira; Obata, Yayoi; Yoshida, Kazumi; Mizoguchi, Junko; Harada, Mamoru; Suekane, Shigetaka; Itoh, Kyogo; Matsuoka, Kei.
Affiliation
  • Noguchi M; Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. noguchi@med.kurume-u.ac.jp
Oncol Res ; 16(7): 341-9, 2007.
Article in En | MEDLINE | ID: mdl-17518272
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Prostatic Neoplasms / Immunotherapy, Active / Epitopes, T-Lymphocyte / Cancer Vaccines / Estramustine Type of study: Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Oncol Res Journal subject: NEOPLASIAS Year: 2007 Document type: Article Affiliation country: Japan Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Prostatic Neoplasms / Immunotherapy, Active / Epitopes, T-Lymphocyte / Cancer Vaccines / Estramustine Type of study: Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Oncol Res Journal subject: NEOPLASIAS Year: 2007 Document type: Article Affiliation country: Japan Country of publication: United States